Navigation Links
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting

ular Edema (DME) is the most prevalent cause of moderate vision loss in patients with diabetes. DME is a common complication of Diabetic Retinopathy (DR), a disease affecting the blood vessels of the retina. A leading cause of blindness in younger adults (under 50), DME occurs when fluid leaks into the center of the macula, the light-sensitive part of the retina responsible for sharp, direct vision. Fluid in the macula can cause severe vision loss or blindness.

Approximately 500,000 Americans currently suffer from DME, with 75,000 new cases arising each year. According to the American Diabetes Association, more than 18 million Americans currently suffer from diabetes and many other people are at risk for developing diabetes. With the incidence of diabetes steadily climbing, it is projected that up to 10 percent of all patients with diabetes will develop DME during their lifetime.

About Regeneron Pharmaceuticals

Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.

This news release discusses historical information and includes forward-looking statements about Regeneron and its products, programs, finances, and business, all of which involve a number of risks and uncertainties, such as risks associated with preclinical and clinical development of our drug candidates, determinations by regulatory and administrative governmental authorities which may delay or restrict our ability to continue to develop or commercialize our drug candidates, competing drugs that are superior to our product candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any collaboration agr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: VEGF Trap Eye Phase Wet AMD Results Reported ARVO Annual Meeting
(Date:5/29/2015)... May 29, 2015  Dr. Yair Walzer has ... vaginal health issues often caused by menopause. The MonaLisa Touch™, ... anesthesia, received FDA clearance in 2014. Dr. Walzer is one ... to offer the special fractional CO 2 laser specifically ... survivors. In 2010 there were greater than ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hgs483/cardiovascular ) has ... "Cardiovascular Drug Delivery - Technologies, Markets and ... delivery to the cardiovascular system is different from ... and physiology of the vascular system; it supplies ... body. Drugs can be introduced into the vascular ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina , ... Research Network and Molecular Health have announced a collaboration ... diagnostic decision support to the majority of cancer patients ... Network will collaborate with Molecular Health to harness the ... identify cohorts from hundreds of thousands of patients to ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
(Date:5/30/2015)... 2015 On Sunday, June 14, 2015, ... – Jefferson Health will host Journey to Survivorship, a ... speaker, brunch and resources for cancer survivors and their ... the event will be Kathy LaTour, editor-at-large for Cure ... then again in 2007, LaTour provides a unique perspective ...
(Date:5/30/2015)... Hod-Hasharon, Israel and Montreal, Canada (PRWEB) May 30, 2015 ... inspection, print process control, and quality assurance, is joining ... offer advanced offline inspection solutions to the worldwide printing ... will provide AVT with a new software engine for ... the specific needs of the printing industry and its ...
(Date:5/30/2015)... May 30, 2015 Thousands of aesthetic ... Aesthetic Meeting, sponsored by the American Society for Aesthetic ... on hand was Zeltiq, the parent company of one ... CoolSculpting. With blazing growth, the one-of-a-kind device just ... , Zeltiq is currently in the news for gaining ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 One of ... lack of local healthcare options available. Often, the ruralness ... healthcare. For those in rural areas feeling the crunch ... health insurance or tired of paying high premiums and ... connecting patients with licensed physicians via the power of ...
(Date:5/30/2015)... Aliso Viejo, CA (PRWEB) May 30, 2015 ... variety of unique designs and animations. Instantly add an elegant ... production while choosing from a range of clean design layouts. ... , ProIntro Magnify is extremely easy to use. Simply ... make changes using the on-screen-controls and parameters in the Inspector ...
Breaking Medicine News(10 mins):Health News:Abington Hospital to Host Cancer Survivorship Event 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 2Health News:AVT and Global Vision Collaborate to Offer Cutting-edge Offline Inspection Solutions for Printing Industry 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2
... have tripled in Idaho (central) and health officials are advising ... 72 cases have been // reported totally by ... Boise, Elmore (17) and Valley counties in southwest Idaho. Statistics ... when compared to the 10 year average period of 23 ...
... charge as he was suffering from Parasomnia, but the victim is ... case against him in Canadian Supreme court. Jan Luedecke was said ... they were both in a drunken state in the same sofa. ... could remember of the act. Parasomnia is a condition in which ...
... funded survey indicates that the ageing population in Kerala which ... a day and most are non-vegetarians. ,Almost ... in Kerala eat three meals a day, according to ‘Kerala ... some interesting problem with the health of the elderly population. ...
... research team comprising Scott Belcher, PhD, did a study ... 'at surprisingly low doses.' , ,Worded by Dr. ... show that oestrogen’s rapid signalling mechanisms are active in ... to be involved with sexual differences or reproductive functions,' ...
... of Alberta has revealed that different parts of the human ... same tasks. This goes to prove that the brains // ... volunteers for the study were called upon to perform simple ... while the functional Magnetic Resonance Imaging (fMRI) technology was used ...
... product like food cans, water pipes, dental sealants and milk ... research team guided by Scott Belcher, PhD, at the University ... December 2005 edition that even low level of Bisphenol A ... of the brain and is also concerned with disease and ...
Cached Medicine News:Health News:Three meals daily Keeps 'Kerala's elderly Healthy 2Health News:Food packaging with Bisphenol A damages the brain 2Health News:Bisphenol A In Food Containers Has Adverse Effect On Brain Tissue 2
... Intramedullary fixation has greatly enhanced ... fractures. The Biomet Low Profile ... in the treatment of unstable ... disease with pathologic or impending ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, Open Ended, Left Notch...
Medicine Products: